IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007, and is headquartered in San Carlos, CA.
Address
825 INDUSTRIAL ROAD
SAN CARLOS, CA 94070
Founded
2007
Number of Employees
557
Website
http://www.iovance.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)